1.GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392:1859-922.
2.Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020; 116:353-67.
3.Luo KQ, Long HB, Xu BC. Reduced apoptosis after acute myocardial infarction by simvastatin. Cell Biochem Biophys. 2015; 71:735-40.
4.Cheng WP, Lo HM, Wang BW, Chua SK, Lu MJ, Shyu KG. Atorvastatin alleviates cardiomyocyte apoptosis by suppressing TRB3 induced by acute myocardial infarction and hypoxia. J Formos Med Assoc. 2017; 116:388-97.
5.Zeng W, Wang X, Xu P, Liu G, Eden HS, Chen X. Molecular imaging of apoptosis: from micro to macro. Theranostics. 2015; 5:559-82.
6.Shekhar A, Heeger P, Reutelingsperger C, Arbustini E, Narula N, Hofstra L, Bax JJ, et al. Targeted imaging for cell death in cardiovascular disorders. JACC Cardiovasc Imaging. 2018; 11:476-93.
7.Belhocine TZ, Blankenberg FG, Kartachova MS, Stitt LW, Vanderheyden JL, HoebersFP, et al. (99m) Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials. Eur J Nucl Med Mol Imaging. 2015; 42:2083-97.
8.Todica A, Zacherl MJ, Wang H, Böning G, Jansen NL, Wängler C, et al. In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga] Annexin A5 and [¹⁸F] FDG PET. J Nucl Cardiol. 2014; 21:1191-9.
9.Lu C, Jiang Q, Hu M, Tan C, Yu H, Hua Z. Preliminary biological evaluation of ¹⁸F-FBEM-Cys-Annexin V a novel apoptosis imaging agent. Molecules. 2015; 20:4902-14.
10.Wuest M, Perreault A, Richter S, Knight JC, Wuest F. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis. Apoptosis. 2019; 24:221-44.
11.Hu Y, Liu G, Zhang H, Li Y, Gray BD, Pak KY, et al. A Comparison of [99mTc] Duramycin and [99mTc] Annexin V in SPECT/CT Imaging Atherosclerotic Plaques. Mol Imaging Biol. 2018; 20:249-59.
12.Li Y, Liu C, Xu X, Lu X, Luo J, Gray B, et al. [99mTc] Tc-duramycin, a potential molecular probe for early prediction of tumor response after chemotherapy. Nucl Med Biol. 2018; 66:18-25.
13.Wang L, Wang F, Fang W, Johnson SE, Audi S, Zimmer M, et al. The feasibility of imaging myocardial ischemic/reperfusion injury using (99m) Tc-labeled duramycin in a porcine model. Nucl Med Biol. 2015; 42:198-204.
14.Audi SH, Jacobs ER, Zhao M, Roerig DL, Haworth ST, Clough AV. In vivo detection of hyperoxia-induced pulmonary endothelial cell death using (99m) Tc-duramycin. Nucl Med Biol. 2015; 42:46-52.
15.Delvaeye T, Wyffels L, Deleye S, Lemeire K, Gonçalves A, Decrock E, et al. Noninvasive whole-body imaging of phosphatidylethanolamine as a cell death marker using 99mTc-duramycin during TNF-induced SIRS. J Nucl Med. 2018; 59:1140-5.
16.Liu Z, Larsen BT, Lerman LO, Gray BD, Barber C, Hedayat AF, et al. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m) Tc-duramycin. Nucl Med Biol. 2016; 43:496-505.
17.Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics. 2004; 16:349-60.
18.Elvas F, Vangestel C, Rapic S, Verhaeghe J, Gray B, Pak K, et al. Characterization of [(99m) Tc] Duramycin as a SPECT imaging agent for early assessment of tumor apoptosis. Mol Imaging Biol. 2015; 17:838-47.
19.Hashmi S, Al-Salam S. Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison. Int J Clin Exp Pathol. 2015; 8:8786-96.
20.Emoto K, Toyama-Sorimachi N, Karasuyama H, Inoue K, Umeda M. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell Res. 1997; 232:430-4.
21.Hanshaw RG, Smith BD. New reagents for phosphatidylserine recognition and detection of apoptosis. Bioorg Med Chem. 2005; 13:5035-42.
22.Yuan G, Liu S, Ma H, Su S, Wen F, Tang X, et al. Targeting phosphatidylethanolamine with fluorine-18 labeled small molecule probe for apoptosis imaging. Mol Imaging Biol. 2019; doi: 10.1007/s11307-019-01460-0.
23.Elvas F, Stroobants S, Wyffels L. Phosphatidylethanolamine targeting for cell death imaging in early treatment response evaluation and disease diagnosis. Apoptosis. 2017; 22(8):971-87.
24.Wu JC, Qin X, Neofytou E. Radiolabeled duramycin: promising translational imaging of myocardial apoptosis. JACC Cardiovasc Imaging. 2018; 11:1834-6.
25.Post JA, Verkleij AJ, Langer GA. Organization and function of sarcolemmal phospholipids in control and ischemic/reperfused cardiomyocytes. J Mol Cell Cardiol. 1995; 27:749-60.
26.Kawai H, Chaudhry F, Shekhar A, Petrov A, Nakahara T, Tanimoto T, et al. Molecular imaging of apoptosis in ischemia reperfusion injury with radiolabeled duramycin targeting phosphatidylethanolamine: effective target uptake and reduced nontarget organ radiation burden. JACC Cardiovasc Imaging. 2018; 11:1823-33.
27.Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol. 1998; 93 3:8-12.
28.Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996; 74:86-107.
29.Misao J, Hayakawa Y, Ohno M, Kato S , Fujiwara T , Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 1996; 94:1506-12.
30.Wu P, Du Y, Xu Z, Zhang S, Liu J, Aa N, et al. Protective effects of sodium tanshinone IIA sulfonate on cardiac function after myocardial infarction in mice. Am J Transl Res. 2019; 11:351-60.
31.Zhou L, Liu X, Wang ZQ, Li Y, Shi MM, Xu Z, et al. Simvastatin treatment protects myocardium in noncoronary artery cardiac surgery by inhibiting apoptosis through miR-15a-5p targeting. J Cardiovasc Pharmacol. 2018; 72:176-85.
32.Scalia R. Statins and the response to myocardial injury. Am J Cardiovasc Drugs. 2005; 5:163-70.